Search the Newsreel

OMCL|Omnicell Inc|Price:37.525|Chg%:+2.155

This article provides a comprehensive stock analysis of Omnicell Inc (OMCL), highlighting its relatively healthy fundamentals, significant growth potential, and fair valuation. Despite recent weak stock market performance, the company maintains strong fundamentals, and analysts have issued "Buy" ratings with a high price target. …

5 Must-Read Analyst Questions From Omnicom Group’s Q2 Earnings Call

GBLI|Global Indemnity Group LLC|Price:28.585|Chg%:+1.370

MNTN (NYSE:MNTN) Posts Earnings Results, Misses Estimates By $0.08 EPS

MNTN Reports Second Quarter 2026 Results

MNTN Inc. (MNTN) Lags Q2 Earnings and Revenue Estimates

Weekly Recap: Omnicell, Inc. Q3/2026 revenue and analyst price target

Omnicell, Inc. (OMCL) reported Q3 revenue between $301-$307 million and guided 2026 revenue to $1.225-$1.245 billion, with an estimated year-end ARR of $660-$680 million. Analysts are optimistic, with a median 12-month price target of $60, suggesting a 31% upside, and the company recently appointed …

Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability

Omnicell (OMCL) reported stronger Q2 2026 revenue and net income, alongside improved profitability for the first half of 2026. The company also raised its full-year 2026 revenue guidance to between US$1.23 billion and US$1.25 billion, signaling higher expectations. Despite the positive outlook, the stock …

Erie Indemnity (ERIE) director gains 65 deferred compensation share credits

Erie Indemnity Company director LuAnn Datesh acquired 65 Directors' Deferred Compensation Share Credits on July 31, 2026, through the company's deferred compensation plan. This transaction increased her total holdings to 4,256.076 Share Credits and 410 Class A common shares. These share credits grant her …

Erie Indemnity (NASDAQ: ERIE) director granted 65 deferred share credits

Erie Indemnity director Thomas B. Hagen received 65 Directors' Deferred Compensation Share Credits on July 31, 2026, increasing his total to 14,625.851 credits. Each credit represents the right to receive one share of Class A common stock upon the end of his board service. …

OmniAb (NASDAQ: OABI) awards 800,000 stock options to its COO

OmniAb, Inc. (NASDAQ: OABI) has granted its Chief Operating Officer, Nwachuku Amechi Ekeke, 800,000 stock options with an exercise price of $1.98 per share, expiring on August 1, 2036. The options will vest over 42 months, beginning August 1, 2026, contingent on Ekeke's continued …

Somnigroup to Post Q2 Earnings: What's in Store for the Stock?

Somnigroup International Inc. (SGI) is set to report its second-quarter 2026 earnings on August 6, 2026, with expectations for bottom and top-line growth. Analysts project earnings of 58 cents per share and revenues of $1.9 billion, driven by innovation, direct-to-consumer sales, and market share …

Erie Indemnity Company (ERIE) CFO adds stock through 401(k) plan move

Erie Indemnity Company's EVP & CFO, Julie Marie Pelkowski, acquired 3.3940 shares of Class A common stock on July 31, 2026, at $242.04 per share through a 401(k) plan, increasing her direct holdings to 675.3940 shares. She also holds 2,107.9220 Incentive Compensation Deferral Plan …

Erie Indemnity (ERIE) EVP reports 401(k) stock acquisition

Douglas Edward Smith, EVP of Erie Indemnity (ERIE), reported a participant-directed acquisition of 2.5770 shares of Class A Common Stock on July 31, 2026, through the company's 401(k) Plan. The shares were acquired at $242.0400 each. Following this transaction, Smith directly holds 5172.2010 shares …

Erie Indemnity (ERIE) EVP gains 11.768 shares in 401(k) plan

Cody Cook, Executive Vice President of Erie Indemnity (ERIE), acquired 11.768 Class A common shares on July 31, 2026, through a participant-directed 401(k) plan at $242.04 per share. Following this transaction, Cook directly holds 1,159.036 Class A shares and has additional Incentive Compensation Deferral …

Erie Indemnity (ERIE) SVP DaBreo acquires 8.959 shares in 401(k) move

Anthony DaBreo, Senior Vice President of Life at Erie Indemnity (ERIE), acquired 8.959 shares of Class A Common Stock on July 31, 2026, at $242.04 per share through a participant-directed 401(k) plan. This transaction increased his direct holdings to 920.633 shares. The acquisition was …

Erie Indemnity (ERIE) EVP acquires 11 shares through 401(k) transaction

Erie Indemnity's Executive Vice President, Sarah Shine, acquired 11.051 shares of Class A common stock through a 401(k) Plan transaction on July 31, 2026, at $242.04 per share. Following this acquisition, her direct holdings increased to 568.573 Class A shares. She also holds 2,712.050 …

Did Strong Q2 Results and Higher 2026 Revenue Guidance Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative?

Omnicell Promotes Chief Operating Officer Nnamdi Njoku to President

Omnicell has promoted its Chief Operating Officer, Nnamdi Njoku, to President, expanding his role to include directing long-term growth, product development, and overseeing global operations. Njoku, who joined Omnicell less than two years ago, will also lead the launch of the Titan XT system …

Vuzix Corporation Revenue Breakdown – SWB:V7XN

Vuzix Corporation (SWB:V7XN) generated 5.35 million EUR in revenue last year. The Smart Glasses, Software, and Accessories segment was its top-performing segment, contributing 3.98 million EUR. The United States was the greatest regional contributor, accounting for 3.62 million EUR of the company's revenue.

Arrowstreet Capital Limited Partnership Trims Stake in Amneal Pharmaceuticals, Inc. $AMRX

MNTN Inc (MNTN) Q2 2026 Earnings Report Preview: What To Expect

Amneal Pharma A earnings beat by $0.07, revenue topped estimates

Amneal Pharma A (NASDAQ: AMRX) reported strong second-quarter results, surpassing analyst estimates with EPS of $0.300 and revenue of $796.2 million. The company also provided optimistic full-year 2026 guidance, expecting EPS between $0.960-$1.060 and revenue between $3.100B-$3.200B. AMRX stock has shown significant growth, increasing …

ETFs Investing in Omnicell, Inc. Stocks

This article lists various ETFs that hold Omnicell, Inc. (OC9) stocks, sorted by market value. It provides key details for each ETF, such as issuer, management style, focus, expense ratio, AUM, price, change, and 3-year NAV total return. The ETFs predominantly target small-cap and …

OABIW Stock Warrant Price and Chart — NASDAQ:OABIW

This page provides an overview of OmniAb, Inc. (OABIW) stock warrant, including its market capitalization of $294.29 million, key financial figures like net income and revenue, and company details. OmniAb, Inc. is a drug discovery company specializing in human monoclonal and bispecific therapeutic antibodies, …

Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance

AMN Healthcare Services Inc (AMN) Shares Fall 3.1% -- GF Value Says Still Overvalued

AMN Healthcare Services Inc (AMN) shares dropped 3.1% to $33.63, with GuruFocus's GF Value indicating the stock is 10.9% overvalued compared to its estimate of $30.32. The company's GF Score of 63/100 points to strong profitability but limited growth potential. Insider selling and a …

Form 4 Erie Indemnity Company For: 3 August By Investing.com

This article from Investing.com is a Form 4 filing for Erie Indemnity Company, dated for August 3rd. It serves as a brief announcement of the filing related to the company, providing minimal details beyond the fact of its publication.

Earnings Preview: AMN to Report Financial Results Post-market on August 06

This article announces that AMN Healthcare Services (AMN) is scheduled to report its financial results post-market on August 06. The report will cover the quarter ended June 2024, with analysts expecting adjusted earnings of $1.00 per share and revenue of $917.9 million. Investors will …

Price to earnings forward of Omnicell, Inc. – NASDAQ:OMCL

This article provides financial information for Omnicell, Inc. (NASDAQ: OMCL), specifically focusing on its forward price-to-earnings ratio. It lists the company's stock market details, financial overview, and acknowledges the data sources used.

ETFs Investing in PT MNC Tourism Indonesia Tbk Stocks

Amneal (AMRX) Stock Looks About Fair Value On Current Earnings

First Trust Advisors LP Acquires 116,873 Shares of Amneal Pharmaceuticals, Inc. $AMRX

Number of shareholders of OmniAb, Inc. – NASDAQ:OABI

This article states that OmniAb, Inc. (NASDAQ: OABI) has "No trades" and provides general information about the company's financials, news, and community on the TradingView platform. It appears to be a stub or an incomplete page that only lists the company and market information, …

Enterprise value to revenue forward of OmniAb, Inc. – BOATS:OABI

This article provides an "Enterprise value to revenue forward" metric for OmniAb, Inc. (BOATS:OABI) on TradingView. It appears to be a financial data point rather than an in-depth analysis, presented within the platform's interface. The content primarily consists of navigation and boilerplate information from …

OMC6324632 Bond Profile — Key Metrics

This article provides a bond profile for Omnicom Group Inc. (OMC6324632), detailing key metrics such as its 5.0% coupon rate, issue date of March 2, 2026, and maturity date of June 2, 2033. It highlights the outstanding amount of $700 million USD and describes …